These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33081372)
21. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist. Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555 [TBL] [Abstract][Full Text] [Related]
22. Bradykinin B1 receptor antagonists as novel analgesics: a retrospective of selected medicinal chemistry developments. Kuduk SD; Bock MG Curr Top Med Chem; 2008; 8(16):1420-30. PubMed ID: 18991728 [TBL] [Abstract][Full Text] [Related]
23. Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice. Rodi D; Buzzi A; Barbieri M; Zucchini S; Verlengia G; Binaschi A; Regoli D; Boschi A; Ongali B; Couture R; Simonato M Neuroscience; 2013 Sep; 248():392-402. PubMed ID: 23811399 [TBL] [Abstract][Full Text] [Related]
24. Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Yamaguchi-Sase S; Hayashi I; Okamoto H; Nara Y; Matsuzaki S; Hoka S; Majima M Inflamm Res; 2003 Apr; 52(4):164-9. PubMed ID: 12755382 [TBL] [Abstract][Full Text] [Related]
30. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists. Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198 [TBL] [Abstract][Full Text] [Related]
31. The bradykinin B1 receptor antagonist BI113823 reverses inflammatory hyperalgesia by desensitization of peripheral and spinal neurons. Schuelert N; Just S; Corradini L; Kuelzer R; Bernloehr C; Doods H Eur J Pain; 2015 Jan; 19(1):132-42. PubMed ID: 25088373 [TBL] [Abstract][Full Text] [Related]
32. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors. Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640 [TBL] [Abstract][Full Text] [Related]
33. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides. Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249 [TBL] [Abstract][Full Text] [Related]
34. Blockade of hippocampal bradykinin B1 receptors improves spatial learning and memory deficits in middle-aged rats. Bitencourt RM; Guerra de Souza AC; Bicca MA; Pamplona FA; de Mello N; Passos GF; Medeiros R; Takahashi RN; Calixto JB; Prediger RD Behav Brain Res; 2017 Jan; 316():74-81. PubMed ID: 27566183 [TBL] [Abstract][Full Text] [Related]
35. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity. Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013 [TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors. Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662 [TBL] [Abstract][Full Text] [Related]
37. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696 [TBL] [Abstract][Full Text] [Related]
38. Differential effect of intranasally administrated kinin B1 and B2 receptor antagonists in Alzheimer's disease mice. Asraf K; Torika N; Roasso E; Fleisher-Berkovich S Biol Chem; 2016 Apr; 397(4):345-51. PubMed ID: 26556847 [TBL] [Abstract][Full Text] [Related]